MX2021014458A - Compuestos triciclicos. - Google Patents

Compuestos triciclicos.

Info

Publication number
MX2021014458A
MX2021014458A MX2021014458A MX2021014458A MX2021014458A MX 2021014458 A MX2021014458 A MX 2021014458A MX 2021014458 A MX2021014458 A MX 2021014458A MX 2021014458 A MX2021014458 A MX 2021014458A MX 2021014458 A MX2021014458 A MX 2021014458A
Authority
MX
Mexico
Prior art keywords
pharmaceutically acceptable
tricyclic compounds
formula
methods
acceptable salts
Prior art date
Application number
MX2021014458A
Other languages
English (en)
Inventor
Sandrine Vendeville
Original Assignee
Aligos Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aligos Therapeutics Inc filed Critical Aligos Therapeutics Inc
Publication of MX2021014458A publication Critical patent/MX2021014458A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Abstract

En la presente descripción se proporcionan compuestos de la Fórmula (I), o sales farmacéuticamente aceptables de estos, composiciones farmacéuticas que incluyen un compuesto descrito en la presente descripción (que incluye sales farmacéuticamente aceptables de un compuesto descrito en la presente descripción) y métodos para sintetizarlas. En la presente descripción también se proporcionan los métodos para tratar enfermedades y/o afecciones con un compuesto de la Fórmula (I), o una sal farmacéuticamente aceptable de este.
MX2021014458A 2019-05-30 2020-05-27 Compuestos triciclicos. MX2021014458A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962854597P 2019-05-30 2019-05-30
PCT/US2020/034746 WO2020243199A1 (en) 2019-05-30 2020-05-27 Tricyclic compounds

Publications (1)

Publication Number Publication Date
MX2021014458A true MX2021014458A (es) 2022-01-06

Family

ID=73552666

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021014458A MX2021014458A (es) 2019-05-30 2020-05-27 Compuestos triciclicos.

Country Status (18)

Country Link
US (1) US11136321B2 (es)
EP (1) EP3976618A4 (es)
JP (1) JP2022534501A (es)
KR (1) KR20220016177A (es)
CN (1) CN113906029A (es)
AU (1) AU2020282707A1 (es)
BR (1) BR112021023967A2 (es)
CA (1) CA3138938A1 (es)
CL (1) CL2021003139A1 (es)
CO (1) CO2021017202A2 (es)
EA (1) EA202192760A1 (es)
IL (1) IL287813A (es)
MA (1) MA56058A (es)
MX (1) MX2021014458A (es)
PE (1) PE20220427A1 (es)
SG (1) SG11202113214QA (es)
TW (1) TW202110845A (es)
WO (1) WO2020243199A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4251625A1 (en) 2020-11-24 2023-10-04 Aligos Therapeutics, Inc. Tricyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0701273D0 (en) 2007-01-24 2007-02-28 Angeletti P Ist Richerche Bio New compounds
WO2008157273A1 (en) 2007-06-14 2008-12-24 Smithkline Beecham Corporation Chemical compounds
RU2016120763A (ru) 2013-10-29 2017-12-05 Медивир Аб Ингибиторы респираторного синцитиального вируса
EA201892034A1 (ru) 2016-03-09 2019-04-30 Эмори Юниверсити Элиминация вируса гепатита в при помощи противовирусных агентов
CN110066278B (zh) * 2017-06-01 2021-06-08 广东东阳光药业有限公司 稠合三环类化合物及其在药物中的应用

Also Published As

Publication number Publication date
US11136321B2 (en) 2021-10-05
WO2020243199A1 (en) 2020-12-03
TW202110845A (zh) 2021-03-16
AU2020282707A1 (en) 2021-12-02
SG11202113214QA (en) 2021-12-30
IL287813A (en) 2022-01-01
CN113906029A (zh) 2022-01-07
US20200407361A1 (en) 2020-12-31
CL2021003139A1 (es) 2022-09-23
PE20220427A1 (es) 2022-03-29
EA202192760A1 (ru) 2022-03-05
CO2021017202A2 (es) 2022-01-17
EP3976618A4 (en) 2023-01-04
MA56058A (fr) 2022-04-06
CA3138938A1 (en) 2020-12-03
EP3976618A1 (en) 2022-04-06
JP2022534501A (ja) 2022-08-01
BR112021023967A2 (pt) 2022-03-08
KR20220016177A (ko) 2022-02-08

Similar Documents

Publication Publication Date Title
WO2019173082A8 (en) Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-ones
MX2021011606A (es) Compuestos dirigidos a prmt5.
MX2021013075A (es) Oxisteroles y metodos de uso de los mismos.
MX2020009530A (es) Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa.
ZA202100485B (en) Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
MX2021012105A (es) Compuestos de pirrol.
WO2020257549A3 (en) Compounds for treatment of pd-l1 diseases
MX2020007947A (es) Inhibidores de erbb/btk.
PH12021550825A1 (en) Quinoline derivatives as alpha4beta7 integrin inhibitors
PH12021551256A1 (en) Pantetheine derivatives and uses thereof
MX2022006783A (es) Nuevos derivados de metilquinazolinona.
MX2022004451A (es) Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1.
MX2021007247A (es) Derivados de rapamicina.
MX2021015056A (es) Compuesto de pirrolopirimidina y uso del mismo.
MX2022004450A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1.
MX2020013297A (es) Compuestos para el tratamiento o la prevencion de enfermedades hepaticas.
PH12019550154A1 (en) Azetidine derivative
PH12020552186A1 (en) Cyanotriazole compounds and uses thereof
PH12019500849A1 (en) Naphthyridinone derivatives and their use inthe treatment of arrhythmia
MX2020008746A (es) Compuestos de sulfonimidoilpurinona 7-sustituidos y sus derivados para el tratamiento y prevencion del cancer de higado.
ZA202204442B (en) Salt forms of a complement component c5a receptor
MX2021009717A (es) Sulfonamidas biciclicas.
PH12021550452A1 (en) Methods of treating mycobacterial infections using tetracycline compounds
MX2021014458A (es) Compuestos triciclicos.
CR20210181A (es) Inhibidores de o-glicoproteína-2-acetamido-2-desoxi-3-d-glucopiranosidasa